Bioequivalence of Levothyroxine Preparations: Issues of Science, Publication, and Advertising

JAMA: The Journal of the American Medical Association

Volumn 278, Issue 11, 1997, Pages 895-896

  Germain, Donald L St ^a   Ridgway, E Chester ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG; THYROXINE; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; THYROTROPIN;

BIOMEDICAL AND BEHAVIORAL RESEARCH; CONTRACT; HEALTH CARE AND PUBLIC HEALTH; HUMAN; INFORMATION DISSEMINATION; JONES MEDICAL INDUSTRIES; JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION; KNOLL PHARMACEUTICAL CO.; MEDICAL RESEARCH; NOTE; PHARMACOKINETICS; PUBLISHING; AREA UNDER THE CURVE; BIOEQUIVALENCE; DRUG COST; DRUG MARKETING; HASHIMOTO DISEASE; HYPOTHYROIDISM; LETTER; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL;

BIOMEDICAL AND BEHAVIORAL RESEARCH; HEALTH CARE AND PUBLIC HEALTH; JONES MEDICAL INDUSTRIES; JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION; KNOLL PHARMACEUTICAL CO.;

BIOMEDICAL RESEARCH; CONTRACTS; DRUGS, GENERIC; EDITORIAL POLICIES; HUMANS; INFORMATION DISSEMINATION; THERAPEUTIC EQUIVALENCY; THYROXINE;

EID: 0030813769     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1997.03550110033018     Document Type: Letter

References (5)

1. Dong BJ, Hauck WW, Gambertoglio JG, et al. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism. JAMA. 1997;277:1205-1213.
2. TSH data not published in the manuscript of Betty J. Dong et al. Knoll Pharmaceutical Company, 1997. Used with permission of Gary Dolch, Knoll Pharmaceutical Company, and available on request from Neil Manowitz, PhD, Knoll Pharmaceutical Company, 3000 Continental Dr N, Mount Olive, NJ 07838 or e-mail: Manowin@ BASF.com.
3. Rennie D. Thyroid storm. JAMA. 1997;277:1238-1243.
4. Correction: JAMA. 1997;277:1762.
5. Rosenberg SA. Secrecy in medical research. N Engl J Med. 1996;334:392-394.